Development and Evaluation of a Noninvasive Microfluidic-Based Paper Analytical Device for Leptospirosis Diagnosis
Analytical Chemistry · 2024
DOI: 10.1021/acs.analchem.4c01934 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2024. Verfasst von Asiamma Ashaiba und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Yenepoya Medical College, Yenepoya (Deemed to be University), Deralakatte, Mangalore 575 018, India. Hauptthemen laut MEDLINE: Leptospirosis, Paper, Leptospira. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Indian Council of Medical Research, Department of Health Research, India.
Abstract (Originalsprache)
Leptospirosis is a re-emerging infectious disease that presents a diagnostic enigma for clinicians with frequent misdiagnosis due to lack of rapid and accurate diagnostic tests, as the current methods are encumbered by inherent limitations. The development of a diagnostic sensor with a sample-in-result-out capability is pivotal for prompt diagnosis. Herein, we developed a microfluidic paper-based analytical device (spin-μPAD) featuring a sample-in-result-out fashion for the detection of Leptospira specific urinary biomarker, sph2 sphingomyelinase, crucial for noninvasive point-of-care testing. Fabrication of paper devices involved precise photolithography techniques, ensuring a high degree of reproducibility and replicability. By optimizing the device's configuration and protein components, a remarkable sensitivity and specificity was achieved for detecting leptospiral sph2 in urine, even at low concentrations down to 1.5 fg/mL, with an assay time of 15 min. Further, the spin-μPAD was validated with 20 clinical samples, suspected of leptospirosis including other febrile illnesses, and compared with gold standard microscopic agglutination test, culture, Lepto IgM ELISA, darkfield microscopy, and Leptocheck WB spot test. In contrast to commercial diagnostic tools, the spin-μPAD was noninvasive, rapid, easy to use, specific, sensitive, and cost-effective. The results highlight the potential of this innovative spin-μPAD for an efficient and dependable approach to noninvasive leptospirosis diagnosis, addressing critical needs in the realms of public health and clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Yenepoya Medical College, Yenepoya (Deemed to be University), Deralakatte, Mangalore 575 018, India.
- Nanomaterial Research Laboratory, Yenepoya Research Centre, Yenepoya (Deemed to be University), Deralakatte, Mangalore 575 018, India.
- Yenepoya Institute of Arts Science Commerce and Management, Yenepoya (Deemed to be University), Mangalore 575 002, India.
- Centre for Nutrition Studies, Yenepoya (Deemed to be University), Mangalore 575 018, India.
ORCID-Profile: Kariate Sudhakara Prasad
Förderung
- Indian Council of Medical Research
- Department of Health Research, India
Zitieren
APA
Ashaiba, A., Sapna, K., Arun, A. B., Tellis, R. C., & Prasad, K. S. (2024). Development and Evaluation of a Noninvasive Microfluidic-Based Paper Analytical Device for Leptospirosis Diagnosis. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c01934
Vancouver
Ashaiba A, Sapna K, Arun AB, Tellis RC, Prasad KS. Development and Evaluation of a Noninvasive Microfluidic-Based Paper Analytical Device for Leptospirosis Diagnosis. Analytical Chemistry. 2024. doi:10.1021/acs.analchem.4c01934
BibTeX
@article{Ashaiba2024,
author = {Ashaiba, Asiamma and Sapna, Kannan and Arun, Ananthapadmanabha Bhagwath and Tellis, Rouchelle C and Prasad, Kariate Sudhakara},
title = {Development and Evaluation of a Noninvasive Microfluidic-Based Paper Analytical Device for Leptospirosis Diagnosis},
journal = {Analytical Chemistry},
year = {2024},
doi = {10.1021/acs.analchem.4c01934}
}
EUVIMED